Issued Patents All Time
Showing 25 most recent of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12337038 | Conjugates comprising cleavable beta-glucuronide-containing linkers | Akbar Husain Khan, Maximillian Taro William Lee, Mattia COCCO, Boliang Deng, Jonathan David BEADLE +5 more | 2025-06-24 |
| 12226490 | Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class | Amandeep Gakhal, Abigail Yu, Ryan Stafford, Jeffrey Hanson, Alice Yam +8 more | 2025-02-18 |
| 12178876 | Conjugates comprising cleavable linkers | Akbar Husain Khan, Maximillian Taro William Lee, Nicole Danielle Bartolo, William Robert Fraser Goundry | 2024-12-31 |
| 12144869 | Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates | Amandeep Gakhal, Abigail Yu, Ryan Stafford, Jeffrey Hanson, Alice Yam +8 more | 2024-11-19 |
| 11744876 | Immunomodulator antibody drug conjugates and uses thereof | Alice Yam, Cristina Abrahams, Willy Solis, Xiaofan LI, Ryan Stafford +4 more | 2023-09-05 |
| 11365263 | Bifunctional cytotoxic agents containing the CTI pharmacophore | Chakrapani Subramanyam, Lawrence Nathan Tumey, Zecheng Chen, Jeffrey M. Casavant | 2022-06-21 |
| 10968242 | Cyclopentane-based modulators of STING (stimulator of interferon genes) | Martin James Wythes, Indrawan James McAlpine, Ryan Patman, Eugene Yuanjin Rui, Mehran Jalaie +1 more | 2021-04-06 |
| 10870706 | Bifunctional cytotoxic agents containing the CTI pharmacophore | Chakrapani Subramanyam, Lawrence Nathan Tumey, Zecheng Chen, Jeffrey M. Casavant | 2020-12-22 |
| 10662204 | Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents | Simon Paul Planken, Hengmiao Cheng, Michael Raymond Collins, Jillian Elyse SPANGLER, Alexei Brooun +4 more | 2020-05-26 |
| 10590115 | Tetrahydroquinazoline derivatives useful as anticancer agents | Simon Paul Planken, Hengmiao Cheng, Michael Raymond Collins, Jillian Elyse SPANGLER, Alexei Brooun +4 more | 2020-03-17 |
| 10544095 | 3-indol substituted derivatives, pharmaceutical compositions and methods for use | Sacha Ninkovic, Michael Raymond Collins, Stefano Crosignani, Indrawan James McAlpine, Stephanie Anne Scales +1 more | 2020-01-28 |
| 10538542 | Cyclopentane-based modulators of STING (stimulator of interferon genes) | Martin James Wythes, Indrawan James McAlpine, Ryan Patman, Eugene Yuanjin Rui, Andrew Fensome +2 more | 2020-01-21 |
| 10391182 | Bifunctional cytotoxic agents | Matthew David Doroski, Zecheng Chen, Hud Lawrence Risley, Jeffrey M. Casavant, Christopher John O'Donnell +2 more | 2019-08-27 |
| 10086085 | Bifunctional cytotoxic agents | Matthew David Doroski, Zecheng Chen, Hud Lawrence Risley, Jeffrey M. Casavant, Christopher John O'Donnell +2 more | 2018-10-02 |
| 9873690 | 3-indol substituted derivatives, pharmaceutical compositions and methods for use | Sacha Ninkovic, Stefano Crosignani, Indrawan James McAlpine, Michael Raymond Collins, Stephanie Anne Scales +1 more | 2018-01-23 |
| 9296686 | Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | Jean-Michel Vernier | 2016-03-29 |
| 9249186 | Cytotoxic peptides and antibody drug conjugates thereof | Matthew David Doroski, Christopher John O'Donnell, Chakrapani Subramanyam, Beth Vetelino, Russell Dushin +2 more | 2016-02-02 |
| 9138486 | Cytotoxic peptides and antibody drug conjugates thereof | Matthew David Doroski, Christopher John O'Donnell, Chakrapani Subramanyam, Beth Vetelino, Russell Dushin +2 more | 2015-09-22 |
| 8884058 | Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | Jean-Michel Vernier | 2014-11-11 |
| 8828401 | Cytotoxic peptides and antibody drug conjugates thereof | Matthew David Doroski, Christopher John O'Donnell, Chakrapani Subramanyam, Beth Vetelino, Russell Dushin +2 more | 2014-09-09 |
| 8829052 | Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK | Jean-Michel Vernier, Dinesh Barawkar, Varaprasad Chamakura, Hassan El Abdellaoul, Zhi Hong | 2014-09-09 |
| 8513443 | Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-3,4-difluoro-2(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | Jean-Michel Vernier | 2013-08-20 |
| 8101799 | Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK | Jean-Michel Vernier, Dinesh Barawkar, Varaprasad Chamakura, Hassan El Abdellaoui, Zhi Hong | 2012-01-24 |
| 8063049 | Inhibitors of MEK | Yung-hyo Koh, Zhi Hong, Jean-Michel Vernier | 2011-11-22 |
| 7820664 | Inhibitors of MEK | Jean-Michel Vernier, Yung-hyo Koh, Zhi Hong | 2010-10-26 |